Fighting type 2 diabetes with FGF1
Nov. 18, 2015—The growth factor FGF1 induces the growth of new insulin-producing beta cells and may help treat type 2 diabetes.
Inflammation, obesity and diabetes
Oct. 29, 2015—Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.
Immune cells and obesity
Sep. 8, 2015—Understanding how macrophage immune cells accumulate in fat tissue and contribute to the pathology of obesity could lead to the development of novel therapeutics for metabolic disorders.
Grant to spur study of ‘brown fat’s’ metabolic mysteries
Jun. 25, 2015—Vanderbilt researchers have received a $2.15 million grant to study the amount and activity of “brown fat” in adults, with the aim of understanding its role in metabolic disease and identifying new therapeutic targets.
New signaling pathway provides clues to obesity
Jan. 22, 2015—A Vanderbilt University-led research team has discovered a molecular “rheostat” in the brain’s appetite control center that may provide new insights into obesity, which is at epidemic levels in this country.
VUCast: Why overweight women lose at work
Dec. 1, 2014—In the latest VUCast: Learn why overweight women lose in the workplace -- especially when it comes to pay; see breakthrough weapons in the fight against infectious diseases; and hear music legend Sheryl Crow speak about her craft. Watch now!
Overactive stress response in obesity
Nov. 7, 2014—An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial.
Lymphocyte study reveals obesity clues
Oct. 16, 2014—Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.
SEC Symposium focused on obesity prevention
Sep. 25, 2014—Chancellor Nicholas S. Zeppos, Provost Susan Wente and several Vanderbilt experts joined colleagues from across the Southeast to discuss obesity at the second annual Southeastern Conference Symposium Sept. 21-23.
Weight regain after gastric bypass
Aug. 15, 2014—Early weight regain after gastric bypass surgery does not reverse metabolic improvements, and the "hunger hormone" ghrelin might indicate who is susceptible to weight regain.
Study examines therapeutic bacteria’s ability to prevent obesity
Jul. 17, 2014—Engineered bacteria that produce a therapeutic compound in the gut prevent obesity in mice, Vanderbilt University investigators have discovered.
Obesity sends immune cells to the brain
Feb. 12, 2014—Obesity causes peripheral immune cells to move to the brain, where they may contribute to inflammation and the pathophysiology of obesity.